Literature DB >> 16637527

Urban myths and the ACT: what is not true and what really matters when it comes to monitoring anticoagulation.

Bruce Searles1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16637527      PMCID： PMC4680769     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN： 0022-1058


× No keyword cloud information.
  5 in total

1.  How does the age of a blood sample affect it's activated clotting time? Comparison of eight different devices.

Authors:  Bruce Searles; Fadi Nasrallah; Edward Darling; Sarah Yarcusko
Journal:  J Extra Corpor Technol       Date:  2002-09

2.  The in vitro effects of aprotinin on twelve different ACT tests.

Authors:  Karen Jones; Fadi Nasrallah; Edward Darling; Nicole Clay; Bruce Searles
Journal:  J Extra Corpor Technol       Date:  2004-03

3.  Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin.

Authors:  W Dietrich; M Jochum
Journal:  J Thorac Cardiovasc Surg       Date:  1995-01       Impact factor: 5.209

Review 4.  Aprotinin and hemostasis monitoring concerns during cardiac surgery.

Authors:  Michael F Swartz; Gregory W Fink; Bruce Searles
Journal:  J Extra Corpor Technol       Date:  2004-12

5.  Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

Authors:  B S Bull; R A Korpman; W M Huse; B D Briggs
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209
  5 in total
  1 in total

1.  Can We Rely on the Activated Clotting Time to Measure Heparin Anticoagulation? A Clinical Evaluation of Two ACT Monitors.

Authors:  Samuel Nilsson; Micael Appelblad; Staffan Svenmarker
Journal:  J Extra Corpor Technol       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.